1) Chang SS, et al : Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer : AUA/ASCO/ASTRO/SUO Guideline. J Urol 198 : 552-559, 2017
2) Koga F, et al : Selective Bladder Preservation With Curative Intent for Muscle-Invasive Bladder Cancer : A Contemporary Review. Int J Urol 19 : 388-401, 2012
3) Royce TJ, et al : Comparative Effectiveness of Bladder-Preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer 17 : 23-31, 2019
4) Weiss C, et al : Management of Superficial Recurrences in an Irradiated Bladder After Combined-Modality Organ-Preserving Therapy. Int J Radiat Oncol Biol Phys 70 : 1502-1506, 2008
5) Efstathiou JA, et al : Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer : The MGH Experience. Eur Urol 61 : 705-711, 2012
6) Tunio MA, et al : Whole-Pelvis or Bladder-Only Chemoradiation for Lymph Node-Negative Invasive Bladder Cancer : Single-Institution Experience. Int J Radiat Oncol Biol Phys 82 : e457-462, 2012
7) Kijima T, et al : Selective Tetramodal Bladder-Preservation Therapy, Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy With Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer : Oncological and Functional Outcomes of 107 Patients. BJU Int 124 : 242-250, 2019
8) Koga F, et al : Selective Bladder-Sparing Protocol Consisting of Induction Low-Dose Chemoradiotherapy Plus Partial Cystectomy With Pelvic Lymph Node Dissection Against Muscle-Invasive Bladder Cancer : Oncological Outcomes of the Initial 46 Cases. BJU Int 109 : 860-866, 2012
9) Koga F, et al : Low-Dose Chemoradiotherapy Followed by Partial or Radical Cystectomy Against Muscle-Invasive Bladder Cancer : An Intent-To-Treat Survival Analysis. Urology 72 : 384-388, 2008
10) 古賀文隆, 他 : 専門医のための泌尿器科手術 ミニマム創内視鏡下・膀胱部分切除術/膀胱憩室切除術―骨盤リンパ節郭清と尿管膀胱新吻合を含めて. 臨泌72 : 1006-1011, 2018
11) Huddart RA, et al : Life and Death of Spare (Selective Bladder Preservation Against Radical Excision) : Reflections on Why the Spare Trial Closed. BJU Int 106 : 753-755, 2010
12) Tanabe K, et al : High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol. Clin Genitourin Cancer 13 : e243-251, 2015
13) Choudhury A, et al : MRE11 Expression Is Predictive of Cause-Specific Survival Following Radical Radiotherapy for Muscle-Invasive Bladder Cancer. Cancer Res 70 : 7017-7026, 2010
14) Koga F, et al : Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer. Int J Mol Sci 19 : 2777, 2018
15) Ngwa W, et al : Using Immunotherapy to Boost the Abscopal Effect. Nat Rev Cancer 18 : 313-322, 2018